Lexeo Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Lexeo Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Lexeo Therapeutics Inc.
Rating: 1.54575
Author: Trendlyne DVM scores

about

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene thera...

4.73 0.08 (1.72%)

65.30% Fall from 52W High

693.7K

XNAS Volume

XNAS 31 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

7.0 / 100

Technically Neutral

54.8 / 100

No estimates available

Lexeo Therapeutics Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Lexeo Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene thera...

65.30% Fall from 52W High

SWOT Analysis

Lexeo Therapeutics Inc. Live Price Chart